Persistent URL of this record https://hdl.handle.net/1887/121555
In Collections
This item can be found in the following collections:
![Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1
- All authors
- Pfeifer, H.; Cazzaniga, G.; Velden, V.H.J. van der; Cayuele, J.M.; Schafer, B.; Spinelli, O.; Akiki, S.; Avigad, S.; Bendit, I.; Borg, K.; Cave, H.; Elia, L.; Reshmi, S.C.; Gerrard, G.; Hayette, S.; Hermanson, M.; Juh, A.; Jurcek, T.; Chillon, M.C.; Homburg, C.; Martinelli, G.; Kairisto, V.; Langen, T.; Lion, T.; Mueller, M.C.; Pane, F.; Rai, L.; Damm-Welk, C.; Sacha, T.; Schnittger, S.; Touloumenidou, T.; Valerhaugen, H.; Vandenberghe, P.; Zuna, J.; Server, H.; Herrmann, E.; Markovic, S.; Dongen, J.J.M. van; Ottmann, O.G.
- Date
- 2019-08-01
- Journal
- Leukemia
- Volume
- 33
- Issue
- 8
- Pages
- 1910 - 1922